English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/66283
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Metformin induces oxidative stress in white adipocytes and raises uncoupling protein 2 levels

AuthorsAnedda, Andrea ; Rial, Eduardo ; González-Barroso, M. Mar
Issue Date1-Oct-2008
PublisherEuropean Society of Endocrinology
Society for Endocrinology
CitationJournal of Endocrinology, 199(1): 33-40 (2008)
AbstractMetformin is a drug widely used to treat type 2 diabetes. It enhances insulin sensitivity by improving glucose utilization in tissues like liver or muscle. Metformin inhibits respiration, and the decrease in cellular energy activates the AMP-activated protein kinase that in turn switches on catabolic pathways. Moreover, metformin increases lipolysis and β-oxidation in white adipose tissue, thereby reducing the triglyceride stores. The uncoupling proteins (UCPs) are transporters that lower the efficiency of mitochondrial oxidative phosphorylation. UCP2 is thought to protect against oxidative stress although, alternatively, it could play an energy dissipation role. The aim of this work was to analyse the involvement of UCP2 on the effects of metformin in white adipocytes. We studied the effect of this drug in differentiating 3T3-L1 adipocytes and found that metformin causes oxidative stress since it increases the levels of reactive oxygen species (ROS) and lowers the aconitase activity. Variations in UCP2 protein levels parallel those of ROS. Metformin also increases lipolysis in these cells although only when the levels of ROS and UCP2 have decreased. Hence, UCP2 does not appear to be needed to facilitate fatty acid oxidation. Furthermore, treatment of C57BL/6 mice with metformin also augmented the levels of UCP2 in epididymal white adipose tissue. We conclude that metformin treatment leads to the overexpression of UCP2 in adipocytes to minimize the oxidative stress that is probably due to the inhibition of respiration caused by the drug
Description8 páginas, 4 figuras -- PAGS nros. 33-40
Publisher version (URL)http://dx.doi.org/10.1677/JOE-08-0278
URIhttp://hdl.handle.net/10261/66283
DOI10.1677/JOE-08-0278
ISSN0022-0795
E-ISSN1479-6805
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
Endocrinol, 199(33-40).pdf280,98 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.